Tajer Benjamin J, Kalu Glory, Jay Sarah, Wynn Eric, Decaux Antoine, Gilbert Paul, Singer Hani D, Kidd Madeline D, Nelson Jeffery A, Harake Noora, Lopez Noah J, Souchet Nathan R, Luong Anna G, Savage Aaron M, Min Sangwon, Karabacak Alparslan, Böhm Sebastian, Kim Ryan T, Froitzheim Tim, Sousounis Konstantinos, Courtemanche Katherine, Han Jihee, Payzin-Dogru Duygu, Blair Steven J, Roy Stéphane, Fei Ji-Feng, Tanaka Elly M, Whited Jessica L
Departmet of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Ave., Cambridge, MA 02318, USA.
Departmet of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Ave., Cambridge, MA 02318, USA; Master de Biologie, École Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Université de Lyon, 69342 Lyon Cedex 07, France.
Methods. 2025 Aug;240:21-34. doi: 10.1016/j.ymeth.2025.03.019. Epub 2025 Apr 3.
The axolotl salamander model has broad utility for regeneration studies, but this model is limited by a lack of efficient cell-culture-based tools. The Axolotl Limb-1 (AL-1) fibroblast line, the only available immortalized axolotl cell line, was first published over 20 years ago, but many established molecular biology techniques, such as lipofectamine transfection, CRISPR-Cas9 mutagenesis, and antibiotic selection, work poorly or remain untested in AL-1 cells. Innovating technologies to manipulate AL-1 cells in culture and study their behavior following transplantation into the axolotl will complement in-vivo studies, decrease the number of animals used, and enable the faster, more streamlined investigation of regenerative biology questions. Here, we establish transfection, mutagenesis, antibiotic selection, and in-vivo transplantation techniques in axolotl AL-1 cells. These techniques will enable efficient culture with AL-1 cells and guide future tool development for the culture and manipulation of other salamander cell lines.
蝾螈模型在再生研究中具有广泛的用途,但该模型因缺乏高效的基于细胞培养的工具而受到限制。蝾螈肢体-1(AL-1)成纤维细胞系是唯一可用的永生化蝾螈细胞系,于20多年前首次发表,但许多成熟的分子生物学技术,如脂质体转染、CRISPR-Cas9诱变和抗生素筛选,在AL-1细胞中效果不佳或仍未经过测试。创新技术以在培养中操纵AL-1细胞并研究其移植到蝾螈体内后的行为,将补充体内研究,减少所用动物的数量,并能够更快、更简化地研究再生生物学问题。在这里,我们建立了蝾螈AL-1细胞的转染、诱变、抗生素筛选和体内移植技术。这些技术将实现对AL-1细胞的高效培养,并指导未来用于培养和操纵其他蝾螈细胞系的工具开发。